Pharmaceutical

Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy

The grant will support the early development of Amygdala’s ALDH2 Inhibitor currently in pre-clinical development.

Aug 2, 2023 - 20:00
Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy
The grant will support the early development of Amygdala’s ALDH2 Inhibitor currently in pre-clinical development.
Read the original article

Tags:

Previous Article

FDA warns of reduced efficacy for oral birth control pill Tydemy

Next Article

The risks of endotoxins in water systems: Where they arise and how to respond

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Congress could stop free public access to government-funded research

Opinion: Congress could stop free public access to gove...

Sep 28, 2023

STAT+: U.S. Supreme Court to review controversial Purdue Pharma bankruptcy settlement

STAT+: U.S. Supreme Court to review controversial Purdu...

Dec 1, 2023

Innate Pharma plans IND of ADC candidate after positive preclinical data

Innate Pharma plans IND of ADC candidate after positive...

Apr 11, 2024